Sign in

CURLF on OTC

Curaleaf

Logo: https://curaleaf.com, Non-free logo, via Wikipedia5

Cannabis company

Curaleaf Holdings, Inc. is an American cannabis company publicly traded on the Canadian Securities Exchange.3 It is headquartered in Vancouver, Canada.1 Its shares trade on OTC under the symbol CURLF.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

$1.3BRevenue, fiscal 20256
-$231.1MNet income, fiscal 20256

Compare with Trulieve Cannabis Corp., USANA Health Sciences or Tilray, or pick any stock.

  • TickerCURLF on OTC1
  • Industrycannabis industry1
  • HeadquartersVancouver, Canada1
  • Websitecuraleaf.com
  • Incorporated inBritish Columbia, Canada7
  • Business address250 Harbor Drive, Third Floor, Stamford, Ct 069027
  • Filer categoryLarge accelerated filer7
  • Legal formCorporation4
  • LEI529900UBH7GFAVEOKA764
  • StatusActive4
  • LEI statusIssued and current4
  • Registered address666 Burrard Street, Suite 1700, V6C 2X8 Vancouver, Canada4
  • Registered withBC Registry Services, 8247489824

See how the biggest companies compare on our leaderboards

Curaleaf Holdings, Inc. is an American cannabis company publicly traded on the Canadian Securities Exchange.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

49.8%Gross margin6
2.0%Operating margin6
-18.2%Net margin6
-5.0%Revenue growth, 20256
-30.6%Return on equity6
0.68×Debt to equity6
$74.3MFree cash flow6

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Retail brought in 73% of the revenue Curaleaf broke down this way in fiscal 2025.

  1. Retail$922.6M673%down 11% from 2024
  2. Wholesale Revenue$332.2M626%up 12% from 2024
  3. Management Fee Income$13.3M61%up 123% from 2024
Products and services by year
Products and services20242025
Retail$1.0B$922.6M
Wholesale Revenue$295.6M$332.2M
Management Fee Income$6.0M$13.3M

Business segments

Domestic brought in 86% of the revenue Curaleaf broke down this way in fiscal 2025.

  1. Domestic$1.1B686%down 11% from 2024
  2. International$172.5M614%up 63% from 2024
Business segments by year
Business segments20242025
Domestic$1.2B$1.1B
International$105.5M$172.5M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue50¢$637.1M
  • Research and development0¢$805.0K
  • Selling, general and admin34¢$428.4M
  • Other costs6¢$78.1M
  • Income tax10¢$123.7M

Out of $1.3B in revenue.6 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending46¢$63.4M
  • Kept or used elsewhere54¢$74.3M

Out of $137.7M of cash from operations.6

Financial statements

Revenue891011126$1.3B in 2025+474% since 2019
0$500.0M$1.0B$1.5B2019: $221.0M$221.0M20192020: $626.6M$626.6M2020+184%2021: $1.2B$1.2B2021+91%2022: $1.3B$1.3B2022+7%2023: $1.3B$1.3B2023+6%2024: $1.3B$1.3B2024−1%2025: $1.3B$1.3B2025−5%
Gross profit891011126$631.0M in 2025+346% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $141.6M$141.6M20192020: $390.5M$390.5M2020+176%2021: $569.8M$569.8M2021+46%2022: $626.4M$626.4M2022+10%2023: $614.4M$614.4M2023−2%2024: $640.8M$640.8M2024+4%2025: $631.0M$631.0M2025−2%
Operating income891011126$25.4M in 2025
-$50.0M0$50.0M$100.0M2019: -$27.7M-$27.7M20192020: $72.4M$72.4M20202021: $58.6M$58.6M2021−19%2022: $65.0M$65.0M2022+11%2023: $42.9M$42.9M2023−34%2024: $24.7M$24.7M2024−42%2025: $25.4M$25.4M2025+3%
Net income891011126-$231.1M in 2025+231% since 2019
-$400.0M-$300.0M-$200.0M-$100.0M02019: -$69.8M-$69.8M20192020: -$56.8M-$56.8M2020−19%2021: -$205.9M-$205.9M2021+263%2022: -$370.1M-$370.1M2022+80%2023: -$281.2M-$281.2M2023−24%2024: -$215.4M-$215.4M2024−23%2025: -$231.1M-$231.1M2025+7%

Every line of the income statement as filed: the last 2 fiscal years, latest first.6

Period ending2025-12-312024-12-31
Total revenues, net$1.3B$1.3B
Cost of goods sold$637.1M$693.5M
Gross profit$631.0M$640.8M
Selling, general and administrative$428.4M$418.5M
Share-based compensation$35.7M$25.7M
Depreciation and amortization$141.4M$171.8M
Total operating expenses$605.6M$616.0M
Income (loss) from continuing operations$25.4M$24.7M
Interest income$663.0K$776.0K
Interest expense-$56.8M-$59.4M
Interest expense related to lease liabilities and financial obligations-$44.1M-$41.3M
Impairment loss-$9.1M-$54.2M
Other income, net$5.6M$16.0M
Total other expense, net-$103.7M-$138.1M
Loss before provision for income taxes-$78.2M-$113.4M
Provision for income taxes-$123.7M-$98.3M
Net loss from continuing operations-$201.9M-$211.6M
Net loss from discontinued operations-$26.2M-$10.4M
Net loss-$228.2M-$222.0M
Less: Net income (loss) attributable to non-controlling interest$2.9M-$6.6M
Net loss attributable to Curaleaf Holdings, Inc.-$231.1M-$215.4M
Net loss per share from continuing operations - basic (in dollars per share)-$0-$0
Net loss per share from continuing operations - diluted (in dollars per share)-$0-$0
Net loss per share from discontinued operations - basic (in dollars per share)-$0-$0
Net loss per share from discontinued operations - diluted (in dollars per share)-$0-$0
Net loss per share attributable to Curaleaf Holdings, Inc. - basic (in dollars per share)-$0.35-$0.32
Net loss per share attributable to Curaleaf Holdings, Inc. - diluted (in dollars per share)-$0.35-$0.32
Weighted average common shares outstanding - basic (in shares)762.1M shares740.8M shares
Weighted average common shares outstanding - diluted (in shares)762.1M shares740.8M shares

Compare Curaleaf with another company

Corporate structure

Curaleaf sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Curaleaf Vancouver, British Columbia, Canada
    • Compass Dispensary Management, LLC Subsidiary · Stamford, Connecticut, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.

What it owns

What Curaleaf reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$854.0M6 Dec 31, 2025$803.4M6 Dec 31, 2024+6.3%
Accumulated depreciation$333.6M6 Dec 31, 2025$260.8M6 Dec 31, 2024+27.9%
Property and equipment, net$520.4M6 Dec 31, 2025$542.6M6 Dec 31, 2024−4.1%
Finance-lease assets$97.6M6 Dec 31, 2025$105.2M6 Dec 31, 2024−7.2%
Operating-lease assets (leased space)$113.3M6 Dec 31, 2025$115.8M6 Dec 31, 2024−2.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$635.1M6 Dec 31, 2025$628.9M6 Dec 31, 2024+1.0%
Intangible assets, net (excluding goodwill)$1.0B6 Dec 31, 2025$1.1B6 Dec 31, 2024−6.8%
Indefinite-lived intangibles (excluding goodwill)$06 Dec 31, 2025$012 Dec 31, 2024
Finite-lived intangibles, gross$1.5B6 Dec 31, 2025$1.5B6 Dec 31, 2024+1.3%
Accumulated amortization$507.4M6 Dec 31, 2025$413.3M6 Dec 31, 2024+22.7%
Finite-lived intangibles, net$1.0B6 Dec 31, 2025$1.1B6 Dec 31, 2024−6.8%

Inventory

ItemLatestA year beforeChange
Inventory, total$225.0M6 Dec 31, 2025$216.9M6 Dec 31, 2024+3.7%
Raw materials$58.9M6 Dec 31, 2025$59.0M6 Dec 31, 2024−0.1%
Work in process$68.0M6 Dec 31, 2025$60.0M6 Dec 31, 2024+13.3%
Finished goods$98.1M6 Dec 31, 2025$97.9M6 Dec 31, 2024+0.2%

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorBoris Jordan named Dec 30, 2021 to Mar 11, 202614
  • Executive OfficerCamilo Lyon named Mar 11, 202614
  • Executive OfficerEd Kremer named Jan 31, 2025 to Mar 11, 202614
  • Executive OfficerPeter Clateman named Dec 30, 2021 to Mar 11, 202614
  • Executive OfficerRahul Pinto named Mar 11, 202614
  • Executive OfficerJames Shorris named Dec 30, 202115
  • Executive OfficerJoseph Bayern named Dec 30, 202115
  • Executive OfficerNeil Davidson named Dec 30, 202115
  • DirectorJoseph Lusardi named Dec 30, 2021 to Mar 11, 202614
  • DirectorKarl Johansson named Dec 30, 2021 to Mar 11, 202614
  • DirectorMichelle Bodner named Jan 31, 2025 to Mar 11, 202614
  • DirectorMitchell Kahn named Dec 30, 2021 to Mar 11, 202614
  • DirectorSasheen Shah named Mar 11, 202614
  • DirectorJaswinder F. Grover, M.D. named Dec 30, 2021 to Jan 31, 202516
  • DirectorPeter F. Derby named Dec 30, 2021 to Jan 31, 202516
  • DirectorShasheen F. Shah named Jan 31, 202516

Timeline

  1. Oct 6, 20268-K Other events17
  2. Oct 6, 20268-K Other events18
  3. Oct 5, 20268-K Executive or director change19
  4. Oct 1, 20268-K Regulation FD disclosure20
  5. Oct 1, 20268-K Regulation FD disclosure21
  6. Sep 16, 20268-K Other events22
  7. Sep 15, 20268-K Other events23
  8. Sep 14, 20268-K Other events24
  9. Sep 8, 20268-K Other events25
  10. Sep 2, 20268-K Other events26
  11. Aug 25, 20268-K Other events27
  12. Aug 18, 20268-K Other events28
  13. Nov 13, 2014Founded Curaleaf is founded4

Calendar

When it reported results

  1. Aug 6, 2026Reported quarterly or annual results29

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

178 filings to the SEC since October 2021: 7 annual reports, 1 quarterly reports, 15 major events, 3 private raises, 152 other. The latest 20:

  1. Oct 6, 2026425 EDGAR
  2. Oct 6, 20268-K EDGAR
  3. Oct 6, 2026F-X EDGAR
  4. Oct 6, 2026SC14D1F/A EDGAR
  5. Oct 6, 2026425 EDGAR
  6. Oct 6, 20268-K EDGAR
  7. Oct 6, 2026F-80 EDGAR
  8. Oct 5, 20268-K EDGAR
  9. Oct 1, 20268-K EDGAR
  10. Oct 1, 20268-K EDGAR
  11. Sep 16, 20268-K EDGAR
  12. Sep 16, 2026425 EDGAR
  13. Sep 15, 2026425 EDGAR
  14. Sep 15, 20268-K EDGAR
  15. Sep 14, 2026425 EDGAR
  16. Sep 14, 20268-K EDGAR
  17. Sep 8, 20268-K EDGAR
  18. Sep 8, 2026425 EDGAR
  19. Sep 2, 2026425 EDGAR
  20. Sep 2, 20268-K EDGAR

The 178 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Feb 18, 2026Raised $345 million in a private offering of debt Form D: 25 investors so far Form D
  2. Jan 17, 2025Raised $67 million in a private offering of debt Form D: 3 investors so far Form D
  3. Dec 15, 2021Raised $135.7 million in a private offering of debt Form D: 15 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
AdvisorShares Investments LLC12,420,961$134.3M16.2%New
Albert D Mason Inc25,009$270.3K0.2%New
Financial Gravity Companies, Inc.33$3570.0%New
Ancora Advisors LLC33$3570.0%New
Sterling Capital Management LLC32$3460.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Curaleaf is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCuraleaf Holdings, Inc.2
  • CIK0001756770
  • Employer ID (EIN)98-146104530
  • Filer statusLarge accelerated filer not an emerging growth company2
  • Incorporated inCanada30
  • Fiscal year endsDecember 312
  • Industry code (SIC)2833 Medicinal Chemicals & Botanical Products2
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance2
  • Business address250 Harbor Drive, Third Floor, Stamford, CT 069022
  • Phone917-717-58752
  • On EDGAR sinceNov 7, 20182
  • Filings219 in all: 6-K (148), 8-K (15), D (11), 425 (10), 40-F (6), F-X (5), 6-K/A (3), EFFECT (3)2
    All 19 form types

    F-10 (3), 40-F/A (2), F-10/A (2), F-80 (2), SC14D1F/A (2), UPLOAD (2), 10-Q (1), CORRESP (1), F-X/A (1), S-8 (1), SC14D1F (1)

  • Latest filingsAnnual report (40-F) Feb 27, 2026
    Quarterly report (10-Q) Aug 6, 2026
    Latest 8-K (8-K) Oct 6, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
    SEC EDGAROther events
  18. 18
    SEC EDGAROther events
  19. 19
  20. 20
  21. 21
  22. 22
    SEC EDGAROther events
  23. 23
    SEC EDGAROther events
  24. 24
    SEC EDGAROther events
  25. 25
    SEC EDGAROther events
  26. 26
    SEC EDGAROther events
  27. 27
    SEC EDGAROther events
  28. 28
    SEC EDGAROther events
  29. 29
  30. 30